← Pelagos Insurance Capital Ltd
| Annual Trend | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| Revenues | $1.2b |
$1.5b
+26.33%
|
$3.6b
+138.25%
|
$2.4b
-32.71%
|
$2.5b
+3.33%
|
$2.1b
-14.95%
|
|
| General and administrative expenses | $130.7m | $165.5m | $82.7m | $94.3m | $96.6m | $103.8m | |
| Net investment income | $20.6m | $40.7m | $119.5m | $190.5m | $184.0m | ($9.1m) | |
| Other income | $1.0m | $1.9m | $100k | $0 | $0 | — | |
| Corporate and other expenses | $2.7m | $20.5m | $4.1m | $1.6m | $1.2m | — | |
| Income before income taxes | $78.7m | $80.1m | $2.0b | $136.4m | $275.6m | $429.0m | |
| Income tax (expense)/benefit | ($400k) | ($17.8m) | $85.3m | ($23.1m) | ($50.1m) | $53.0m | |
| Income tax expense, all of which relates to unrealized gains on available-for-sale investments | $2.4m | $8.1m | ($9.7m) | ($2.8m) | ($9.2m) | $53.0m | |
| Net income | $78.3m |
$62.3m
-20.43%
|
$2.1b
+3322.95%
|
$113.3m
-94.69%
|
$225.5m
+99.03%
|
$376.0m
+66.74%
|
|
| Reclassification of net realized losses/(gains) recognized in net income | — | $2.5m | $700k | $24.7m | ($4.6m) | — | |
| Earnings per common share (in dollars per share) | $0.35 | $0.27 | $18.65 | $0.98 | $2.12 | — | |
| Earnings per diluted common share (in dollars per share) | $0.34 | $0.26 | $18.65 | $0.98 | $2.11 | — | |
| Weighted average basic common shares outstanding (in shares) | 195.5m | 194.3m | 114.3m | 115.2m | 106.2m | — | |
| Weighted average diluted common shares outstanding (in shares) | 200.4m | 199.3m | 114.3m | 115.6m | 106.7m | — | |
| Gross premiums written | $2.8b | $3.0b | $3.6b | $4.4b | $4.7b | $4.8b | |
| Reinsurance premiums ceded | ($1.2b) | ($1.2b) | ($1.4b) | ($2.0b) | ($1.7b) | — | |
| Net premiums written | $1.6b | $1.9b | $2.1b | $2.4b | $3.0b | $3.2b | |
| Change in net unearned premiums | ($446.9m) | ($357.9m) | ($304.0m) | ($136.5m) | ($714.9m) | — | |
| Net premiums earned | $1.2b | $1.5b | $1.8b | $2.3b | $2.3b | — | |
| Net realized and unrealized investment gains/(losses) | $13.5m | ($33.7m) | $4.9m | ($28.6m) | $22.8m | — | |
| Net gain on distribution of The Fidelis Partnership | $0 | $0 | $1.6b | $0 | $0 | — | |
| Losses and loss adjustment expenses | $696.8m | $830.2m | $698.8m | $1.2b | $1.1b | — | |
| Policy acquisition expenses (includes The Fidelis Partnership commissions of $328.8 (2024: $311.1 and 2023: $225.3)) | $250.1m | $384.4m | $723.8m | $999.7m | $990.1m | $654.3m | |
| Net foreign exchange (gains)/losses | ($400k) | $6.8m | ($4.1m) | ($1.6m) | ($500k) | — | |
| Financing costs | $35.4m | $35.5m | $35.5m | $33.8m | $47.7m | — | |
| Unrealized gains on available-for-sale investments | ($36.1m) | ($96.5m) | $82.4m | $9.6m | $46.4m | — | |
| Comprehensive income attributable to common shareholders | $34.4m | ($36.9m) | $2.2b | $144.8m | $258.1m | — | |
| Total expenses | $1.1b | $1.4b | $1.5b | $2.3b | $2.2b | $1.7b | |
| Total other comprehensive income | ($33.9m) | ($89.5m) | $72.7m | $31.5m | $32.6m | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.